[theold]

Dr Lin Xiaoxi of Shanghai Ninth People's Hospital is leading the nation's only new drug study on AVM.

Lin's team used some novel approaches in their research and received praise from international colleagues. After 16 weeks of treatment, some trial participants experienced a lesion decrease of more than 50 percent. The success was published in the medical journal in The New England Journal of Medicine.


https://www.shine.cn/news/metro/2411016675/